Artegodan GmbH and Others v Commission of the European Communities.

Core Citations

WORK EXPRESSION OF in

• Artegodan GmbH and Others v Commission of the European Communities.

This document cites

• Upjohn Ltd v The Licensing Authority established by the Medicines Act 1968 and Others.
• Angelopharm GmbH contra Freie Hansestadt Hamburg.
• Affish BV contra Rijksdienst voor de keuring van Vee en Vlees.
• Commission of the European Communities v Gerot Pharmazeutika GmbH.
• Commission of the European Communities v Schuck GmbH.



See all quotations

• Commission of the European Communities v Laboratórios Roussel Ldª and Laboratoires Roussel Diamant SARL.
• Commission of the European Communities v Laboratórios Roussel Ldª and Roussel Iberica SA.
• Reino Unido de Gran Bretaña y de Irlanda del Norte contra Comisión de las Comunidades Europeas.
• Commission of the European Communities v Bruno Farmaceuitici SpA and Others.
• Pierrel SpA y otros contra Ministero della Sanità.
• Commission of the European Communities v Cambridge Healthcare Supplies Ltd.
• Commission of the European Communities v Artegodan GmbH.
• Etablissements Armand Mondiet SA contra Armement Islais SARL.
• Commission of the European Communities v Laboratoires pharmaceutiques Trenker SA.
• Automobiles Peugeot SA y Peugeot SA contra Comisión de las Comunidades Europeas.
• United Kingdom of Great Britain and Northern Ireland v Commission of the European Communities.
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products
• Council Directive 93/41/EEC of 14 June 1993 repealing Directive 87/22/EEC on the approximation of national measures relating to the placing on the market of high- technology medicinal products, particularly those derived from biotechnology
• Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
• Council Directive 83/570/EEC of 26 October 1983 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
• Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products
• Council Directive 87/22/EEC of 22 December 1986 on the approximation of national measures relating to the placing on the market of high-technology medicinal products, particularly those derived from biotechnology
• Treaty establishing the European Community